Prime Medicine Insider Trades
NASDAQ: PRMEHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Prime Medicine insider activity
No Prime Medicine insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows GV 2021 GP, L.L.C. & GV 2021 GP, L.P. & GV 2021, L.P. & Alphabet Inc. (10% Owner) buying 1,500,000 shares at $3.30 on Aug 1, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put PRME's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
PRME insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Aug 1, 2025 | ARCH Venture Partners X, LLC & ARCH Venture Partners X, L.P. & ARCH Venture Partners X Overage, L.P. & ARCH Venture Fund X, L.P. & ARCH Venture Fund X Overage, L.P. & CRANDELL KEITH & Burow Kristina & GILLIS STEVEN10% Owner | Buy | 3,030,300 | $10.00M | Form 4 |
| Aug 1, 2025 | ARCH Venture Partners XII, LLC & ARCH Venture Partners XII, L.P. & ARCH Venture Fund XII, L.P.10% Owner | Buy | 3,030,300 | $10.00M | Form 4 |
| Aug 1, 2025 | NELSEN ROBERTDirector | Buy | 3,030,300 | $10.00M | Form 4 |
| Aug 1, 2025 | GV 2021 GP, L.L.C. & GV 2021 GP, L.P. & GV 2021, L.P. & Alphabet Inc.10% Owner | Buy | 1,500,000 | $4.95M | Form 4 |
| Jun 30, 2025 | Liu David R.10% Owner | Buy | 21,000 | $52.83K | Form 4 |
| Jun 23, 2025 | Liu David R.10% Owner | Buy | 21,000 | $45.40K | Form 4 |
| Jun 16, 2025 | Liu David R.10% Owner | Buy | 21,000 | $31.20K | Form 4 |
| Jun 11, 2025 | Liu David R.10% Owner | Buy | 21,000 | $33.59K | Form 4 |
| May 21, 2025 | Reine AllanChief Executive Officer | Buy | 125,000 | $147.15K | Form 4 |
| May 21, 2025 | LEE ANN L.Chief Technical Officer | Buy | 100,000 | $113.00K | Form 4 |
| May 20, 2025 | Brudnick RichardChief Business Officer | Buy | 20,000 | $23.79K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4